Navigation Links
DOE JGI plumbs termite guts to yield novel enzymes for better biofuel production
Date:11/21/2007

of lignocellulose into fermentable sugars in their tiny bioreactor hindguts. Scaling up this process so that biomass factories can produce biofuels more efficiently and economically is another story. To get there, we must define the set of genes with key functional attributes for the breakdown of cellulose, and this study represents an essential step along that path."

Nature paper first author Falk Warnecke is a postdoctoral fellow in the Hugenholtz lab. Other DOE JGI authors include Natalia Ivanova, Rotem Sorek, Susannah Tringe, Hector Garcia Martin, Victor Kunin, Daniel Dalevi, Julita Madejska, Edward Kirton, Darren Platt, Ernest Szeto, Asaf Salamov, Kerrie Barry, Natalia Mikhailova, Nikos Kyrpides, and Director Rubin.

These findings follow on the heels of the announcement by DOE Secretary Samuel Bodman in June that DOE will invest up to $375 million in three new Bioenergy Research Centers (http://genomicsgtl.energy.gov/centers/) to accelerate basic research in the development of cellulosic ethanol and other biofuels. DOE JGI will conduct genome sequencing in support of these centers.

The termite hindgut whodunit builds upon DOE JGI's pioneering "metagenomic" research, where genetic material is isolated, identified, and characterized directly from environmental samples, providing a profile of a particular (often extreme) ecological niche. Published investigations by DOE JGI include glimpses into such diverse slices of the biosphere as acid mine drainage, a gutless worm, farm soil, submerged whalebones, and sewage sludge.

Currently among the scores of projects in the sequencing queue at DOE JGI are metagenomes from contents of the Tammar wallaby forestomach, the Asian longhorned beetle gut, and other exotic species that promise to be treasure troves of enzymes involved in cellulose deconstruction. These targets were submitted through DOE JGI's Community Sequencing Progra
'/>"/>

Contact: David Gilbert
degilbert@lbl.gov
925-296-5643
DOE/Joint Genome Institute  
Source:Eurekalert

Page: 1 2 3 4 5

Related biology technology :

1. Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy
2. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
3. Novel Technology Breaks Through Cancer Pain
4. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
5. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
6. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
7. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
8. NIST team develops novel method for nanostructured polymer thin films
9. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
10. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
11. European Expert Consortium Combines Forces to Develop a Novel Pandemic Influenza Vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DOE JGI plumbs termite guts to yield novel enzymes for better biofuel production
DOE JGI plumbs termite guts to yield novel enzymes for better biofuel production
(Date:11/24/2009)..., Iceland, November 24 d...ed the approval of all of its,"first day" motions ...elaware,(the "Bankruptcy Court"). deCODE last week...er 11 of the United States Bankruptcy Code with th...y the Bankruptcy Court allow the company to contin...
(Date:11/24/2009)... /PRNewswire-Asia/ -- Shanghai Biolaxy announced t...FDA) has approved the,investigational new drug app...n), an innovative insulin formulation to treat dia...e its first phase I clinical study. , Dia...lucose and poor,metabolism. The complications of d...
(Date:11/24/2009)...point has been met for patients with advanced-stag...EC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEterna ...pany"), a global biopharmaceutical company focused...d positive efficacy data from a Phase 2 study with...8 (formerly AN-152), in patients with advanced or ...
(Date:11/24/2009)...09 Arena Pharmaceuticals... company is scheduled to present at the Piper Jaff... 1, 2009 at 11:30 a.m. Eastern Time (8:30 a.m. Pac...k City. Jack Lief, Arena,s President and Chief Exe...w of the company, including its clinical developme...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...dia Site Live allows WVU to stream video from thei...an watch their classes from a computer at their co...l courses will be available on the web beginning t...need more nurse educators to teach the next genera...f nursing at WVU School of Nursing. By using Media...
...t only does WisconsinGuide.com save time, it has a...terson said that the site is a great example of re...to bring the real time economy to the traditional ...ners the ability to quickly, easily and affordably...nsinGuide.com was featured on the WMTV NBC 15 morn...
...e controversial May edition of the Harvard Busine... Nicholas Carr entitled IT Doesn,t Matter , questi...d a stir in the business and technology communitie... Marketing , a small company based in Appleton whi...d uses technology to impact the sales, marketing a...
Other Biology Technology:Sonic Foundry Facilitates Nursing Education 2Sonic Foundry Facilitates Nursing Education 3Wisconsin Tourism Aided by Internet Technology 2Wisconsin Tourism Aided by Internet Technology 3IT Does Matter! 2IT Does Matter! 3
(Date:11/26/2009)...countries has shown that closing schools in the ev... significant role in reducing illness transmission...BMC Infectious Diseases compared opportunities fo...finding that they were reduced when schools are sh...sity, Belgium, led a team of European researchers ...
(Date:11/26/2009)...ccus Aureus ) and other drug-resistant bacteria co...ototype devices have been developed to offer safe,... , Two prototype devices have been developed: on... hands and feet) in hospitals and public spaces wh... to shoot bacteria-killing agents into infested ch...
(Date:11/25/2009)...ives. In addition to mammalian immune systems that...d bacteriophages, viruses that kill half the bacte...and another class of microorganisms called archaea... deep-sea volcanic vents) manage just fine, thank ...system that helps protect them from many viruses a...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Ventilation After Breathing Tube Removal May Alter Outcomes 54416 1Ventilation After Breathing Tube Removal May Alter Outcomes 54416 2MRI May Not Improve Breast Cancer Outcome 54414 1China Medicine Announces Second Quarter 2009 Results 54412 1China Medicine Announces Second Quarter 2009 Results 54412 2China Medicine Announces Second Quarter 2009 Results 54412 3China Medicine Announces Second Quarter 2009 Results 54412 4China Medicine Announces Second Quarter 2009 Results 54412 5China Medicine Announces Second Quarter 2009 Results 54412 6China Medicine Announces Second Quarter 2009 Results 54412 7China Medicine Announces Second Quarter 2009 Results 54412 8China Medicine Announces Second Quarter 2009 Results 54412 9China Medicine Announces Second Quarter 2009 Results 54412 10China Medicine Announces Second Quarter 2009 Results 54412 11China Medicine Announces Second Quarter 2009 Results 54412 12China Medicine Announces Second Quarter 2009 Results 54412 13China Medicine Announces Second Quarter 2009 Results 54412 14
...lcohol spectrum disorder (FASD) and Fetal alcohol ...uding facial defects, short stature, and mental an...pus, is a valuable tool for understanding early ve..., easy to work with and very responsive to environ...ress the mechanism underlying the characteristics ...
...re,s Institute of Bioengineering and Nanotechnolog...oporous material using a unique surfactant templat... been predicted only mathematically (see reference... reference below), the IBN scientists report that ...h institute, is the first hexagonal nanoscale cons...
...LPHIA - A collaboration of University of Pennsylva...hesiologists have identified a fluorescent anesthe...ning more precise information about how anesthetic...e rapidly test new anesthetic compounds in the sea...dy is published online in the Proceedings of the ...
Other Biology News:Frogs reveal clues about the effects of alcohol during development 2First tri-continuous mesoporous Silica complex structure developed in Singapore 2Penn researchers demonstrate a new model for drug discovery with a fluorescent anesthetic 2Penn researchers demonstrate a new model for drug discovery with a fluorescent anesthetic 3
Rabbit Anti-GRASP1 Polyclonal Antibody, Unconjugated from Abcam
Porcine Galanin , 3-[125I]iodotyrosyl26 Conjugated/Tagged from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-CRIPT Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-HES1 Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products: